SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Monsanto Co.
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2539 20 0 MTC
Emcee:  David Luckie Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
864 Merck's Cox-2 Pain Drug to Get Expedited FDA Review (Update1) BloombAnthony Wong-1/11/1999
863 I downloaded the draft label from.....somewhere...maybe it was on this thread. jttmab-1/11/1999
862 AHA! So Monsanto/Searle CAN say something about Celebrex being better...this isDan Spillane-1/11/1999
861 Here's an article you'll find interesting, courtesy of a pointer from ajttmab-1/11/1999
860 I believe the answer can be found on the Monsanto website: www.monsanto.SteveR-1/11/1999
859 It's all a matter of timing, level and degree. Prescription brand-name drugDan Spillane-1/11/1999
858 Like I mentioned several messages ago, Monsanto had turned the prescription braDan Spillane-1/11/1999
857 Jim, here's a Bloomberg article, reporting on the WSJ report (<i>citiAnthony Wong-1/11/1999
856 Anthony, "...expects to claim.....likely to be approved..." And thjttmab-1/11/1999
855 Merck and Co. Inc. (NYSE:MRK - news) expects to claim that its arthritis mediciAnthony Wong-1/11/1999
854 Aren't we all a bit overconfident that the other drug makers will not reducPaul Kelly-1/9/1999
853 ADVISORY/Kaiser Permanente in California has Made No Decision On Celebrex --(BAnthony Wong-1/8/1999
852 You have the analysis right Dan. The missing piece of the puzzle is the split bJoe Wesley-1/8/1999
851 Who-a boy! The discussion about generics and generic prices is irrelevant. Why?Dan Spillane-1/8/1999
850 Monsanto has rattled the pain-relief drug industry in a big way! By pricing CeDan Spillane-1/8/1999
849 insurers would be comparing to generic naproxen which would be closer to .24 pecoyote-1/8/1999
848 Something wrong with this picture. There are no generics, this is a brand new David Winkler-1/8/1999
847 Wellpoint, Others Limit Coverage of Celebrex, Times Reports Bloomberg NeAnthony Wong-1/8/1999
846 Thursday January 7, 7:28 pm Eastern Time Low Celebrex cost seen curbing price jopawa-1/7/1999
845 Thursday January 7, 6:00 pm Eastern Time Pioneer posts wider-than-expected Q1 jopawa-1/7/1999
844 Monsanto Co. Maintained 'Recommend List' at Goldman Sachs BloombAnthony Wong-1/7/1999
843 Monsanto Co. Reiterated 'Buy' at Parker Hunter Princeton, New Jersjopawa-1/7/1999
842 Anthony, Henry, I don't understand why companies see it necessary to selecjopawa-1/6/1999
841 Monsanto Co. Maintained 'Recommend List' at Goldman Sachs Princejopawa-1/6/1999
840 Monsanto Co. Maintained 'Outperform' at Schroder & Co. Princjopawa-1/6/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News